More articles from Plenary Session 7: Process Design Strategies for Prevention of Viral Contaminations

You have access
Viral Safety of Plasma-derived Products
Mahmood Farshid

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 737-753; DOI: https://doi.org/10.5731/pdajpst.2011.00848
You have access
Practicing Safe Cell Culture: Applied Process Designs for Minimizing Virus Contamination Risk
Robert D. Kiss

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 715-729; DOI: https://doi.org/10.5731/pdajpst.2011.00852
You have access
Application of Risk Assessments in the Design of the Overall Viral Control Strategy Used during the Manufacture and Testing of Live Virus Vaccines
Sridhar Pennathur

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 730-736; DOI: https://doi.org/10.5731/pdajpst.2011.00851
You have access
Application of Quality by Design in the Control of Adventitious Viruses: Gaps in Current Processes in the Prevention of Virus Contaminants
Barry Cherney

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 754-766; DOI: https://doi.org/10.5731/pdajpst.2011.00849

Main menu